CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia. [electronic resource]
Producer: 20180108Description: 2462-9 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- B-Lymphocytes -- drug effects
- Cell Cycle -- drug effects
- Cyclin E -- metabolism
- Cyclin-Dependent Kinase 2 -- metabolism
- Drug Resistance, Neoplasm -- drug effects
- Female
- Humans
- Interleukin-6 -- metabolism
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Molecular Targeted Therapy -- methods
- Myeloid Cell Leukemia Sequence 1 Protein -- metabolism
- Proliferating Cell Nuclear Antigen -- metabolism
- Receptors, Interleukin-6 -- metabolism
- STAT3 Transcription Factor -- metabolism
- Tumor Cells, Cultured
- bcl-X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.